Veterinary Medicine Market Report 2026
Global Outlook – By Product (Drugs, Vaccines, Medical Feed Additives), By Animal Type (Companion Animals, Livestock Animals), By Route Of Administration (Oral Route, Parental Route, Topical Route), By Distribution Channel (Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies), By End-Use (Reference Laboratories, Point-Of-Care Testing Or In-House Testing, Veterinary Hospitals And Clinics, Other End-users) – Market Size, Trends, Strategies, and Forecast to 2030
Veterinary Medicine Market Overview
• Veterinary Medicine market size has reached to $33.21 billion in 2025 • Expected to grow to $47.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Growing Pet Owner Population Driving The Veterinary Medicine Market • Market Trend: Ethno-Veterinary Medicines Transforming Veterinary Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Veterinary Medicine Market?
Veterinary medicine refers to the medical field focused on the prevention, diagnosis, and treatment of diseases in animals. It is used to maintain the health and welfare of pets, livestock, and wildlife. Veterinary medicine also plays a key role in public health by controlling zoonotic diseases. The main products of veterinary medicine are drugs, vaccines, and medical feed additives. Drugs refer to medications that are pharmacologically active chemicals that are given to animals when they are ill and improve animal health and development. The animals, such as companion and livestock animals, are administered through oral, parental, and topical routes of administration and are distributed through various distribution channels, including veterinary hospital pharmacies and retail veterinary pharmacies, used by various end-users such as reference laboratories, point-of-care testing/in-house testing, veterinary hospitals and clinics, and others.
What Is The Veterinary Medicine Market Size and Share 2026?
The veterinary medicine market size has grown strongly in recent years. It will grow from $33.21 billion in 2025 to $35.74 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growing livestock population, increasing pet ownership, rising prevalence of animal diseases, expansion of veterinary hospitals and clinics, government initiatives supporting animal health.What Is The Veterinary Medicine Market Growth Forecast?
The veterinary medicine market size is expected to see strong growth in the next few years. It will grow to $47.94 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to advancements in veterinary biotechnology, increasing adoption of digital veterinary solutions, rising demand for animal vaccines, growth in companion animal healthcare spending, expansion of veterinary pharmaceutical manufacturing. Major trends in the forecast period include rising focus on zoonotic disease control, increasing demand for preventive veterinary care, growth in animal welfare awareness, expansion of tele-veterinary services, adoption of evidence-based veterinary practices.
Global Veterinary Medicine Market Segmentation
1) By Product: Drugs, Vaccines, Medical Feed Additives 2) By Animal Type: Companion Animals, Livestock Animals 3) By Route Of Administration: Oral Route, Parental Route, Topical Route 4) By Distribution Channel: Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies 5) By End-Use: Reference Laboratories, Point-Of-Care Testing Or In-House Testing, Veterinary Hospitals And Clinics, Other End-users Subsegments: 1) By Drugs: Antimicrobials, Anti-inflammatory Drugs, Pain Management Drugs, Hormonal Drugs, Anesthetics 2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Multivalent Vaccines 3) By Medical Feed Additives: Nutritional Supplements, Antimicrobial Feed Additives, Probiotics And Prebiotics, Enzymes, Growth PromotersWhat Is The Driver Of The Veterinary Medicine Market?
The increase in number of pet owners is expected to propel the growth of the veterinary medicine market. Pet owners are individuals who own or adopt a pet animal. Pet owners take care of their pets and their health. Pet owners are rising because more people are seeking companionship and emotional support from pets, leading to a higher rate of pet adoption and ownership. Veterinary medicine helps pet owners by preventing, diagnosing, and treating illnesses in their animals, ensuring their pets remain healthy and live longer, happier lives. For instance, in 2023, according to the Shelter Animals Count, a US-based non-governmental organization, in 2023 dog adoptions increased by 109,000 compared to 2022, indicating positive growth in adoption rates. However, the total number of dogs adopted in 2023 remains nearly 108,000 lower than in the prior year. Therefore, the growing pet owner population is driving the veterinary medicine industry.Key Players In The Global Veterinary Medicine Market
Major companies operating in the veterinary medicine market are Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Virbac, Boehringer Ingelheim International GmbH, Kindred Biosciences Inc., Biogenesis Bago SA, Indian Immunologicals Limited, Neogen Corporation, Hester Biosciences Limited, Phibro Animal Health, Vetoquinol S.A., IDEXX Laboratories Inc., Heska Corporation, Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Bayer Animal Health
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Veterinary Medicine Market Trends and Insights
Major companies operating in the veterinary medicine market are innovating new products, such as ethno-veterinary medicines, to gain a competitive edge in the market. Ethno-veterinary medicines are medicines made from Ayurvedic formulations and are designed to treat animal diseases. For instance, in August 2023, Milma, an India-based dairy company, launched ethno-veterinary medicines. Ethno-veterinary medicines are used as low-cost alternatives to allopathic veterinary drugs. This medicines lessen the burden of veterinary expenses on farmers and provide a cost-effective solution for animal healthcare. This medicines are a simple, cost-effective, farmer-friendly tool that are used as preventives and curativesWhat Are Latest Mergers And Acquisitions In The Veterinary Medicine Market?
In December 2024, Animalcare Group plc, a UK-based animal health and veterinary pharmaceutical company, acquired Randlab, for approximately $120 million. With this acquisition, Animalcare aimed to strengthen and expand its presence in the global equine veterinary market, broaden its product portfolio and accelerate earnings growth by leveraging Randlab’s established brands and geographic reach in Australia, New Zealand and the Middle East. Randlab is an Australia-based equine veterinary pharmaceutical company that specializes in developing, manufacturing and distributing a broad portfolio of equine health products and prescription medicines targeted at equine veterinarians and their clients.
Regional Outlook
North America was the largest region in the veterinary medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the veterinary medicine market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Veterinary Medicine Market?
The veterinary medicine market consists of sales of dicloxacillin, erythromycin, tetracycline, and retinoids, which are naturally occurring and synthetic compounds with vitamin A activity. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Veterinary Medicine Market Report 2026?
The veterinary medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Veterinary Medicine Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $35.74 billion |
| Revenue Forecast In 2030 | $47.94 billion |
| Growth Rate | CAGR of 7.6% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product, Animal Type, Route Of Administration, Distribution Channel, End-Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Virbac, Boehringer Ingelheim International GmbH, Kindred Biosciences Inc., Biogenesis Bago SA, Indian Immunologicals Limited, Neogen Corporation, Hester Biosciences Limited, Phibro Animal Health, Vetoquinol S.A., IDEXX Laboratories Inc., Heska Corporation, Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Bayer Animal Health |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |